Qiming Corporate GP VI, Ltd., 10% Owner at Alamar Biosciences, Inc. (ALMR), sold 187,636 shares at $29.93 ($5.7M) on 2026-10-30, disclosed to the SEC on 2026-11-03.
Open-market sale of $5.7M ALMR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.93 | 11,354 | $340K | 6.0% |
| 2 | $29.93 | 1,309 | $39K | 0.7% |
| 3 | $29.93 | 13,593 | $407K | 7.2% |
| 4 | $29.93 | 48,659 | $1.5M | 25.7% |
| 5 | $30.70 | 1,080 | $33K | 0.6% |
| 6 | $30.70 | 40,112 |
| $1.2M |
| 21.7% |
| 7 | $30.70 | 11,205 | $344K | 6.1% |
| 8 | $30.70 | 9,359 | $287K | 5.1% |
| 9 | $31.96 | 950 | $30K | 0.5% |
| 10 | $31.96 | 3,400 | $109K | 1.9% |
| 11 | $31.96 | 793 | $25K | 0.4% |
| 12 | $31.96 | 92 | $3K | 0.1% |
| 13 | $33.31 | 31 | $1K | 0.0% |
| 14 | $33.31 | 273 | $9K | 0.2% |
| 15 | $33.31 | 327 | $11K | 0.2% |
| 16 | $33.31 | 1,169 | $39K | 0.7% |
| 17 | $29.84 | 28,404 | $848K | 14.9% |
| 18 | $29.84 | 763 | $23K | 0.4% |
| 19 | $29.84 | 6,628 | $198K | 3.5% |
| 20 | $29.84 | 7,935 | $237K | 4.2% |
| 21 | $30.63 | 3 | $92 | 0.0% |
| 22 | $30.63 | 30 | $919 | 0.0% |
| 23 | $30.63 | 36 | $1K | 0.0% |
| 24 | $30.63 | 131 | $4K | 0.1% |
| Total | $30.25 avg | 187,636 | $5.7M | 100% |
| Filing → |
| ALMR | SELL | 2026-10-19 | $4.8M | — | Filing → |